LD-2 disclosure · 4th Quarter - Report
SAGE THERAPEUTICS
Client
- Location
- Massachusetts · United States of America
Registrant
- Description
- Pharmaceutical manufacturing
- Location
- Cambridge, Massachusetts, United States of America
Lobbying activities
2 issuesHealth Issues
Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. H.R.5376 - Inflation Reduction Act of 2022.
LobbyistsVANESSA PROCTER · JULIE GARNER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Senate drug pricing provisions and Medicare Part D reforms in reconciliation language. Telehealth Medicare physician reimbursement. H.R.4058/S.2061 - Telemental Health Care Access Act of 2021 to remove barriers to telemental health services for Medicare beneficiaries. H.R.5376 - Inflation Reduction Act of 2022.
LobbyistsVANESSA PROCTER · JULIE GARNER
TargetedSENATE · HOUSE OF REPRESENTATIVES